clx202 topic 1 (1 slide per page)

66
Bioprocess Applications CLx202

Upload: catherine-williams

Post on 01-Feb-2016

11 views

Category:

Documents


0 download

DESCRIPTION

bpa

TRANSCRIPT

Page 1: CLx202 Topic 1 (1 Slide Per Page)

Bioprocess Applications

CLx202

Page 2: CLx202 Topic 1 (1 Slide Per Page)

CLx202 Course Module

Introduction to Biopharmaceutical Manufacturing Process Sterilisation and its application in the

pharmaceutical industry Sterile and aseptic processing Sterile Filtration Pharmaceutical Cleanrooms Pharmaceutical Utilities

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 2

Page 3: CLx202 Topic 1 (1 Slide Per Page)

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 3

Page 4: CLx202 Topic 1 (1 Slide Per Page)

WHAT’S SO SPECIAL ABOUT BIOLOGICS? Size does matters

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 4

Page 5: CLx202 Topic 1 (1 Slide Per Page)

Small Molecule Drugs Molecular weight < 900 Da (daltons) Initially extracted from natural products Often chemically modified Often by chemical synthesis

Aspirin: C9H8O4 (M=118) Penicillin G: C16H18N2O4S (M=334)

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 5

Page 6: CLx202 Topic 1 (1 Slide Per Page)

Biopharmaceuticals Large molecule weight

Protein Nucleic acid (DNA/RNA)

By genetically engineered organisms

Insulin: C257H379N65O75S6 (M=5808) Avastin: C6638H10160N1720O2108S44

(M≈149000)

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 6

Page 7: CLx202 Topic 1 (1 Slide Per Page)

Small Molecule Drugs Vs Biopharmaceuticals (in terms of size and complexity)

Small Molecule Small Protein Large Protein

Aspirin 21 atoms 180 Da

Growth Hormone e.g Protropin ~3000 atoms

~22 kDa

Business Jet 15000 kg

Antibody (IgG) e.g. Avastin

~ 25000 atoms ~ 149 kDa

Bicycle 10 kg Car 2000 kg

Abilify 57 atoms 448 Da

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 7

Page 8: CLx202 Topic 1 (1 Slide Per Page)

Proteins

Amino acid chain

Primary Secondary Quaternary Tertiary

α-helix

β-sheet

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 8

Page 9: CLx202 Topic 1 (1 Slide Per Page)

Proteins Macromolecules composed of amino acids

as basic component o Mix & match out of 20 amino acids

Consists of C, H, O, N, & S atoms Function as

o Enzymes o Structural skeleton of cells (e.g. actin) o Nutrition o Hormones (e.g. insulin) o Immune system (e.g. antibodies)

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 9

Page 10: CLx202 Topic 1 (1 Slide Per Page)

Amino Acids

An α-carbon atom with R group

Amino group (-NH2)

Carboxyl group (-COOH)

Exist as zwitterions

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 10

Page 11: CLx202 Topic 1 (1 Slide Per Page)

20 Amino Acids

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 11

Page 12: CLx202 Topic 1 (1 Slide Per Page)

Peptide / Amide Bonds

Formed via condensation of 2 or more amino acids

Linked amino acids chains via amide linkages are known as peptides

Peptide bonds form the primary structure of proteins

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 12

Page 13: CLx202 Topic 1 (1 Slide Per Page)

Posttranslational Modifications Covalent modification of proteins

(generally enzymes-aided) during or after protein biosynthesis

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 13

But why need modification? To modify polypeptides into useful and

meaningful proteins To convert immature proteins to fully

functional proteins

Page 14: CLx202 Topic 1 (1 Slide Per Page)

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 14

Posttranslational Modifications

Page 15: CLx202 Topic 1 (1 Slide Per Page)

Posttranslational Modifications

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 15

Page 16: CLx202 Topic 1 (1 Slide Per Page)

Biopharmaceuticals/Vaccines

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 16

Insulin Hormone (glucose) Erythropoietin Hormone (blood) Lucentis Age-related vision loss Avastin Angiogenesis inhibitor Gardasil/Cervarix HPV vaccine Herceptin Cancer drug Humira Rheumatoid Arthritis Remicade Rheumatoid Arthritis Factor VIII, Factor IX Haemophilia

Page 17: CLx202 Topic 1 (1 Slide Per Page)

Trends in Pharmaceuticals

Drugs Biologics

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 17

Page 18: CLx202 Topic 1 (1 Slide Per Page)

Bio Manufacturing: Production Process

Stock Culture

Shake Flask Seed fermentor Production

fermentor

Supernatant

Product Extraction

Product Purification

Fill & Finish Packaging

Medium Sterilization

Medium Formulation

Medium Raw Material

Culture fluid

Bio mass

Cell separation

2. Sterilisation and its application in the pharmaceutical industry

3. Sterile and aseptic processing 4. Sterilizing Filtration 5. Pharmaceutical clean rooms 6. Pharmaceutical utility systems

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 18

Page 19: CLx202 Topic 1 (1 Slide Per Page)

UPSTREAM PROCESS Making the product

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 19

Page 20: CLx202 Topic 1 (1 Slide Per Page)

BACKGROUND Cells multiply and need more space

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 20

Page 21: CLx202 Topic 1 (1 Slide Per Page)

Fermentation Harvest

Lysis Primary recovery

Clarification Purification

Polishing Buffer exchange

Formulation

mechanical

chemical

thermal

sieve

Bag filters

Precipitation & Depth filtration

centrifugation

UF

IEX

Chrom

UF

SEC

UF

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 21

Page 22: CLx202 Topic 1 (1 Slide Per Page)

Cell Culture - Upstream

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 22

2. Sterilisation and its application in the pharmaceutical industry 3. Sterile and aseptic processing 4. Sterilizing Filtration 5. Pharmaceutical clean rooms 6. Pharmaceutical utility systems

Page 23: CLx202 Topic 1 (1 Slide Per Page)

Purification - Downstream

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 23

2. Sterilisation and its application in the pharmaceutical industry 3. Sterile and aseptic processing 4. Sterilizing Filtration 5. Pharmaceutical clean rooms 6. Pharmaceutical utility systems

Page 24: CLx202 Topic 1 (1 Slide Per Page)

Fill and Finish

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 24

2. Sterilisation and its application in the pharmaceutical industry 3. Sterile and aseptic processing 4. Sterilizing Filtration 5. Pharmaceutical clean rooms 6. Pharmaceutical utility systems

Page 25: CLx202 Topic 1 (1 Slide Per Page)

FERMENTATION

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 25

Page 26: CLx202 Topic 1 (1 Slide Per Page)

Fermentation

Utilizes o Microbial, animal and plant cells o Components of cells such as enzymes to

manufacture new products and destroy harmful wastes

Generally reactions where a raw organic feed is converted into product by action of microbes or enzymes.

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 26

Page 27: CLx202 Topic 1 (1 Slide Per Page)

2 Types of Fermentation

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 27

Enzymes promoted − enzyme catalyzed reactions

Micro-organisms/cells promoted o Micro-organisms o Animal cells o Plant cells

Page 28: CLx202 Topic 1 (1 Slide Per Page)

Common Fermentation

Baker’s yeast Beer Cheese Penicillin Vaccines Monoclonal antibodies Tamiflu production process (partial)

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 28

Page 29: CLx202 Topic 1 (1 Slide Per Page)

CELL GROWTH And you thought rabbits multiply fast…

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 29

Page 30: CLx202 Topic 1 (1 Slide Per Page)

During Fermentation … … Cell growth and production are measured as a function of the culture environment/conditions. Condition examples are:

Temperature pH O2 level (in solution, dissolved O2) Nutrient concentrations Stirrer speed

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 30

Page 31: CLx202 Topic 1 (1 Slide Per Page)

Batch Culture Kinetics Phases 1. Lag phase

Slow cell growth as cells are adapting to new environment 2. Log / Exponential phase

Exponential cell growth Reaches maximum growth rate

3. Post-log phase Cell growth continues at lower rate than the maximum

4. Stationary phase Cell growth ≈ Cell death ∴ viable cell number maintain constant Cells metabolism still ongoing

5. Death phase Cell growth < Cell death or growth stopped ∴ viable cell number ↓ Cell death rate exceeds cell growth Death becomes obvious

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 31

Page 32: CLx202 Topic 1 (1 Slide Per Page)

Batch Growth Curve

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 32

VCD

t

Lag phase

Log / Exponential phase

Stationary phase

Death phase

Page 33: CLx202 Topic 1 (1 Slide Per Page)

Specific Growth Rate, μ Lag phase: μ = 0 Log phase: μ = μmax

Stationary phase: μ = 0 Death phase: μ = negative

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 33

Page 34: CLx202 Topic 1 (1 Slide Per Page)

Why Exponential Growth?

XdtdXX

dtdX µ=∴∝

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 34

Page 35: CLx202 Topic 1 (1 Slide Per Page)

Doubling time, td?

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 35

Page 36: CLx202 Topic 1 (1 Slide Per Page)

Fermentation

Some derived/calculated parameters use to describe fermentation process performance are Specific Growth Rate, μ (unit of per time, e.g. h-1, d-1) Specific Production Rate, QP (unit of mass per cell

per time, e.g. 𝐩𝐩𝐩𝐩𝐜𝐜𝐜𝐜𝐜𝐜𝐜𝐜∙𝐝𝐝𝐝𝐝𝐝𝐝

)

Product Yield or Titer Cell Density or Concentration, CD or X (unit of cells

per vol, e.g. cells/mL, cells/L) Viable Cell Density, VCD (same unit as CD)

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 36

Page 37: CLx202 Topic 1 (1 Slide Per Page)

Unit Prefix Refresher Prefix Symbol Factor Mass Length Volume peta P 1015 tera T 1012 giga G 109 mega M 106 t kilo k 103 kg km

100 g m m3 deci d 10-1 dm centi c 10-2 cm milli m 10-3 mg mm L, dm3

micro μ 10-6 μg μm mL, cm3 nano n 10-9 ng nm μL pico p 10-12 pg pm femto f 10-15 fm

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 37

Page 38: CLx202 Topic 1 (1 Slide Per Page)

Product Formation

Basic Assumption o Cells produce all the time

o All cells produce at same rate (QP) How much product does each cell produce per time?

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 38

How can we increase production?

Page 39: CLx202 Topic 1 (1 Slide Per Page)

Specific Production Rate, QP Unit of pg

cell∙day

Base on previous assumption,

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 39

Higher QP ≅ Higher Product Yield

QP of 1 pgcell∙day

means that it takes 1012

cells to produce 1 g of product in a day.

How long would 1011 cells take to produce 1 g?

Page 40: CLx202 Topic 1 (1 Slide Per Page)

Man-hour, Cell-day… Man-hour is the amount of work performed by an average worker per hour.

∴ If we want more work done, we can – hire more workers or – have workers work longer hours

Likewise, to get more production in a fermenter, increase amount of cells or extend the production duration

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 40

Page 41: CLx202 Topic 1 (1 Slide Per Page)

VCD

t

Total Number of Cell-days

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 41

IVCD: Time integral of viable cell density

∫=ω

α

dtXIVCD t

Page 42: CLx202 Topic 1 (1 Slide Per Page)

Total Number of Cell-days

IVCD: Time Integral of Viable Cell Density

In practical:

⋅+

∆⋅+

daylast

dayfirst

ii

ii

dVCDVCDIVCD

tVCDVCDIVCD

_

_

1

1

12

2

𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼 = � 𝐼𝐼𝐼𝐼𝐼𝐼𝑡𝑡 𝑑𝑑𝑑𝑑𝑡𝑡

𝑡𝑡0

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 42

Page 43: CLx202 Topic 1 (1 Slide Per Page)

IVCD Example

Fermenter size = 10 L, Run duration = 4 days

Day 0: X = 3 × 108 cells/L

Day 1: X = 3 × 108 cells/L

Day 2: X = 6 × 108 cells/L

Day 3: X = 1 × 109 cells/L

Day 4: X = 1 × 109 cells/L

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 43

Page 44: CLx202 Topic 1 (1 Slide Per Page)

Determine QP Fermenter size = 10 L, Run duration = 4 days

IVCDtotal = 2.55 × 109 cell∙day/L The fermentation produced a titer of 510 mg/L.

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 44

How much product does each cell produce everyday?

Page 45: CLx202 Topic 1 (1 Slide Per Page)

CELL HARVESTING / BIOMASS REMOVAL Clarification or Concentration

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 45

Page 46: CLx202 Topic 1 (1 Slide Per Page)

Where is the Product?

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 46

Page 47: CLx202 Topic 1 (1 Slide Per Page)

Cell Harvesting / Biomass Removal

Centrifugation / Separation

•Use centrifugal forces to separate substances of differing denseness

Tangential / Cross Flow Filtration (TFF)

•Use membrane to separate substances of differing size, charge etc.

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 47

Cell Harvesting / Biomass Removal

Cell Culture

Supernatant / Permeate

Biomass / Retentate

Page 48: CLx202 Topic 1 (1 Slide Per Page)

1: Feed, 2: Feed for liquid water or concentrate recycle, 3: Centripetal pump for clarified liquid, 4: Disc stack, 5: Inlet chamber for product, 6: Concentrate chamber, 7: Nozzles,

8: Concentrate discharge, 9: Clarified liquid discharge Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 48

Page 49: CLx202 Topic 1 (1 Slide Per Page)

Cross or Tangential Flow Filtration

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 49

Page 50: CLx202 Topic 1 (1 Slide Per Page)

DOWNSTREAM PROCESS Removing everything except the product

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 50

Page 51: CLx202 Topic 1 (1 Slide Per Page)

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 51

Page 52: CLx202 Topic 1 (1 Slide Per Page)

Downstream Processing

Typically starts after cell separation Mostly Protein Purification steps

o Filtration o Chromatography

Include measures to reduce viral load Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 52

Page 53: CLx202 Topic 1 (1 Slide Per Page)

Types of Chromatography

Liquid chromatography o Size exclusion o Hydrophobic interaction o Ion exchange o Affinity

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 53

Page 54: CLx202 Topic 1 (1 Slide Per Page)

25.5 t • Fermentation

1.43 t

• Primary recovery (cell harvesting, cell disruption, inclusion body recovery)

• Step yield 90%

62.5 t • Chemical conversion (IB solubilisation, DF, IEX, refolding, DF, HIC) • Step yield 60%

2.94 t • Enzymatic conversion • Step yield 90%

15 kg • Final purification (DF, IEX, DF, RP, DF, SEC, UF, crystallisation, filtration) • Step yield 60%

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 54

Page 55: CLx202 Topic 1 (1 Slide Per Page)

Yield Losses

nLY

−⋅=

%1001%100

Y: Yield L: percent yield loss for one step n: number of steps

%9.59%100

%51%10010

=

−⋅=

Y

Y

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 55

Example: o 5% loss per step o 10 steps

Page 56: CLx202 Topic 1 (1 Slide Per Page)

Total Yield

Calculate the overall yield of the insulin process!

4321 YYYYYYield itotal ⋅⋅⋅=∏=

=totalYield

Σ – capital Sigma for sums

Π – capital Pi for product

itotal YYield ∏=

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 56

Page 57: CLx202 Topic 1 (1 Slide Per Page)

FILL & FINISH Sterile or Finished Dosage Form

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 57

Page 58: CLx202 Topic 1 (1 Slide Per Page)

Common Finished Dosage Forms

Pre-filled syringes Liquid vials Lyophilized vials Cartridges

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 58

Page 59: CLx202 Topic 1 (1 Slide Per Page)

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 59 Fill Vials

Page 60: CLx202 Topic 1 (1 Slide Per Page)

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 60

FILL & FINISH Sterile or Finished Dosage Form

Industrial Lyophiliser

Page 61: CLx202 Topic 1 (1 Slide Per Page)

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 61

Page 62: CLx202 Topic 1 (1 Slide Per Page)

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 62

Page 63: CLx202 Topic 1 (1 Slide Per Page)

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 63

Page 64: CLx202 Topic 1 (1 Slide Per Page)

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 64

Page 65: CLx202 Topic 1 (1 Slide Per Page)

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 65

Page 66: CLx202 Topic 1 (1 Slide Per Page)

Last edited: Sep 2015 NYP - SCL - BPA - Topic 1 - © NYP 66